Support for Patients and Communities Reauthorization Act
Summary
Official Summary
Support for Patients and Communities Reauthorization Act
This bill reauthorizes through FY2028 and modifies various grants, programs, and activities that address substance use and misuse.
This includes reauthorizing (1) data collection, education, and surveillance activities; (2) grants and other support for substance use disorder prevention, treatment, and recovery; (3) student loan repayment and other programs for the substance use disorder workforce; and (4) programs for addressing trauma, particularly for children, youth, and their families. Generally, the modifications expand programs.
Additionally, the bill modifies provisions related to the scheduling of controlled substances, including by incorporating illicit xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer) into schedule III of the Controlled Substances Act.
Further, the bill makes permanent a requirement that Medicaid programs cover medication-assisted treatment for individuals with substance use disorders.
Bill texts
All available records shown.
Timeline
Latest companion bill action
S-3106: SUPPORT for Patients and Communities Reauthorization Act of 2023Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Considered as unfinished business. (consideration: CR H6836)
House of Representatives
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 386 - 37 (Roll no. 715). (text: 12/11/2023 CR H6790-6794)
House of Representatives
View voteMotion to reconsider laid on the table Agreed to without objection.
House of Representatives
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Senate